![2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide structure](/static/products/896/896062-51-4.webp)
2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide
TL;DR: 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide (CAS 896062-51-4) is a chemical compound with molecular formula C25H30N2O5 and molecular weight 438.21548 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-[1]benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholin-4-ylethyl)acetamide
Also Known As: 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide, 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-[1]benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholin-4-ylethyl)acetamide, 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-[1]benzofuro[3,2-g]chromen-3-yl)-N-[2-(morpholin-4-yl)ethyl]acetamide
Technical Specifications
| Molecular Formula | C25H30N2O5 |
| Molecular Weight | 438.21548 g/mol |
| XLogP | 2.7 |
| Topological Polar Surface Area (TPSA) | 81.0 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Exact Mass | 438.21548 Da |
| Heavy Atoms | 32 |
| Complexity | 761.0 |
| SMILES | CC1=C(C(=O)OC2=C(C3=C(C=C12)C4=C(O3)CCCC4)C)CC(=O)NCCN5CCOCC5 |
| InChIKey | QDKBEGYAWSVGGO-UHFFFAOYSA-N |
Chemical Property Profile of 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide
Property Insights of 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide
The XLogP value of 2.7 suggests moderate lipophilicity, balancing water solubility and membrane permeability for 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide. The TPSA of 81.0 Ų falls within the moderate polarity range, balancing permeability and solubility for 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide. Following Lipinski's Rule of Five, 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide has 1 hydrogen bond donor(s) and 6 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
What is the CAS number of 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide?
The CAS number of 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide is 896062-51-4.
What is the molecular formula of 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide?
The molecular formula of 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide is C25H30N2O5.
What is the molecular weight of 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide?
The molecular weight of 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide is 438.21548 g/mol.
Where can I buy 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide?
You can request a quote for 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Does CoreyChem offer custom synthesis for 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide?
Yes, CoreyChem provides custom synthesis services for 2-(4,11-dimethyl-2-oxo-6,7,8,9-tetrahydro-2H-benzofuro[3,2-g]chromen-3-yl)-N-(2-morpholinoethyl)acetamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.